• Events
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions & Resources
    • Legislative Policy Positions
    • State Actions & Resources
    • Policy Supported
  • Take Action
    • Take Action
    • We The Patients
    • Events
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions & Resources
    • Legislative Policy Positions
    • State Actions & Resources
    • Policy Supported
  • Take Action
    • Take Action
    • We The Patients
    • Events
  • Donate

Tag: Asthma

Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Asthma

Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Asthma

Sep 28, 2021 | ICER

On September 16, 2021, ICER released its draft evidence report, “Tezepelumab for Severe Asthma: Effectiveness and Value.” This guide provides a framework for considering what aspects of the new treatment for asthma are important to patients and their families, and how...
Read more
Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Asthma

Season 2 | Episode 21: Looking for Help with Allergies and Asthma?

May 28, 2021 | Access, Featured

On this episode of the podcast, Terry and Bob discuss the fight for accessible and affordable therapies for the 60 million Americans with asthma and allergies. They note how such patients with lung conditions have been disproportionately affected by Covid-19.  They...
Read more

Categories

  • Access
  • Advocacy
  • California
  • Coalitions
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • Event
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Patients Rising Now Statement: ICER’s ‘Updates’ are Thinly Veiled Strategy to Continue Discriminatory Tactics
  • Patients Rising Now Issues Statement on E&C IRA Hearing
  • Patients Rising Now Signs onto Letter to Increase Patient Access to Pharmacy Services
  • Patients Rising Now Issues ‘Must Pass for Patients’ List for Congress
  • National Patient Advocacy Group: Patients Shut Out of Price Negotiation Process

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Events
  • We The Patients
  • Facebook
  • X
  • Instagram
All rights reserved. © 2023 Patients Rising Now